glp-1 agonists drug class Classification of glucagon-like peptide-1 receptor Data from: The GLP-1 Agonists and Obesity:

PLoS ONE 15 , e0237598 (2020)

This helps to keep people feeling full for longer after eating, stimulates the pancreas to secrete more insulin (the most important blood sugar-reducing hormone), and acts in the brain to reduce appetite and cravings

10.1136/gutjnl-2016-312431 43

Patients may experience more pronounced gastrointestinal symptoms during titration, which can influence their willingness to continue treatment

This could potentially prevent the progression of liver damage in NAFLD

For people with chronic obesity and cardiovascular complications, GLP-1 receptor agonists are preferred to amphetamine-based therapies like phentermine, which can worsen blood pressure, heart rate, anxiety, and insomnia